Shots:

• The approval is based on seven clinical studies including three of which were pivotal efficacy and safety studies in pain relief which involves assessing of ibuprofen (250 mg) + acetaminophen (500 mg) vs ibuprofen and acetaminophen monothx in patients with acute pain symptoms
• The study demonstrated that the FD combination achieved superior efficacy then the monotherapy in patients
• Advil Dual Action is combination of ibuprofen and acetaminophen resulting to an exclusive pain reliever and will be available over-the-counter nationwide in 2020

Click here to read full press release/ article

Ref: PRNewswire | Image: GSK